@misc{reinthaler_revival_of_2018, 
author={Reinthaler, M., Ozga, A.-K., Sinning, D., Curio, J., Al-Hindwan, H.S., Baeckemo-Johansson, J., Jung, F., Lendlein, A., Rauch, G., Landmesser, U.},
title={Revival of transcatheter PFO closure: A meta-analysis of randomized controlled trials - impact of shunt size and age},
year={2018},
howpublished = {journal article},
doi = {https://doi.org/10.1016/j.ahj.2018.03.025},
abstract = {According to our meta-analysis TPC plus antiplatelets was superior in terms of stroke prevention when compared to Med-Tx. Furthermore, patients with moderate to severe shunts and those younger than 45 years of age were found to benefit most from TPC.},
note = {Online available at: \url{https://doi.org/10.1016/j.ahj.2018.03.025} (DOI). Reinthaler, M.; Ozga, A.; Sinning, D.; Curio, J.; Al-Hindwan, H.; Baeckemo-Johansson, J.; Jung, F.; Lendlein, A.; Rauch, G.; Landmesser, U.: Revival of transcatheter PFO closure: A meta-analysis of randomized controlled trials - impact of shunt size and age. American Heart Journal. 2018. vol. 201, 95-102. DOI: 10.1016/j.ahj.2018.03.025}}